$BCRX BIOCRYST PHARMACEUTICALS INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in BIOCRYST PHARMACEUTICALS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in BIOCRYST PHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in BIOCRYST PHARMACEUTICALS INC for free.

CIK Number: 0000882796
IRS Number: 621413174
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: BCRX
Company Address: 4505 EMPEROR BOULEVARD SUITE 200 DURHAM 27703

BioCryst Pharmaceuticals, Inc. designs, optimizes and develops novel small molecule drugs that block key enzymes involved in the pathogenesis of diseases. Its drug candidates include rapivab, alpivab, rapiacta, peramiflu, BCX7353, BCX9930, BCX9250, Galidesivir, and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC.

Market Capitalization: $427.06M
Prev close: $5.67
Average Daily Volume: 981,787
Days Low: $5.55
Year Low: $1.63
Year High: $7.56

BIOCRYST PHARMACEUTICALS INC Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
ASELAGE STEVEDirector5,00028,350shares bought: 5,000 / shares sold: 0 STRONG BUYMay 24 2019yesterday
STAAB THOMAS R IISenior Vice President and CFO134,926765,030shares bought: 202,509 / shares sold: -220,324 SELLMay 20 20195 days ago

View all BIOCRYST PHARMACEUTICALS INC insiders.

BIOCRYST PHARMACEUTICALS INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 24 2019BCRXBIOCRYST PHARMACEU ...ASELAGE STEVEDirectorBuyP3.573,00010,7105,0002 K to 5 K (+150.00 %)
May 20 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseM1.424,7506,74561,000
May 20 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...SellS7.452,50018,625125,176127.7 K to 125.2 K (-1.96 %)
May 20 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...SellS7.727,25055,970127,676134.9 K to 127.7 K (-5.37 %)
May 20 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...BuyM1.424,7506,745134,926130.2 K to 134.9 K (+3.65 %)
May 16 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseM1.424,7506,74565,750
May 16 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseM1.424,5006,39070,500
May 16 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...SellS7.927,25057,420130,176137.4 K to 130.2 K (-5.28 %)
May 16 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...BuyM1.424,7506,745137,426132.7 K to 137.4 K (+3.58 %)
May 16 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...SellS7.624,50034,290132,676137.2 K to 132.7 K (-3.28 %)
May 16 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...BuyM1.424,5006,390137,176132.7 K to 137.2 K (+3.39 %)
May 13 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseM5.519,75053,723131,250
May 13 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseM5.519,75053,723141,000
May 13 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...SellS7.769,75075,660132,676142.4 K to 132.7 K (-6.85 %)
May 13 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...BuyM5.519,75053,723142,426132.7 K to 142.4 K (+7.35 %)

View all BIOCRYST PHARMACEUTICALS INC insider transactions.